Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nancy Newman, MD
Emory University Hospital Atlanta, Georgia, United States, 30322
Principal Investigator - Patrick Yu-Wai-Man, PhD
John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, CB2 0PY, United Kingdom
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitair Ziekenhuis Gent
Ghent, Belgium
- Chno Les Quinze Vingts
Paris, Paris, France
- Irccs Istituto Delle Scienze Neurologiche Di Bologna (isnb) Clinica Neurologica
Bologna, Italy
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- Taipei Veterans General Hospital
Taipei, Taiwan
- Moorfields Eye Hospital
London, Greater London, United Kingdom
- Doheny Eye Center Ucla Pasadena
Pasadena, California, United States
- University of Colorado Health Eye Center
Aurora, Colorado, United States
- Emory Healthcare - the Emory Clinic
Atlanta, Georgia, United States
- Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
- Department of Ophthalmology, Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Departments of Neurology and Ophthalmology, Wills Eye Hospital and Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Vanderbilt Eye Institute
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2018
- Primary completion
- 23 Jul 2024
- Completion
- 23 Jul 2024
- Last update posted
- 16 Apr 2026
- Registered enrollment
- 98
- Registry id
- NCT03293524
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.